Skip to main content
. 2021 May 12;51(8):1260–1270. doi: 10.1017/S0033291721001641

Table 3.

Associations between quality criteria and effect sizes when compared to passive control conditions at posttreatment

k Hedges' g I2 p
Trials not meeting criterion Trials meeting criterion
Q1: Diagnosis 77 0.75 1.15 80.71*** 0.074
(outlier-adjusted) 73 0.75 1.04 73.45*** 0.125
Q2: Manual 77 1.68 1.04 80.84*** 0.046*
(outlier-adjusted) 73 1.33 0.97 74.02*** 0.224
Q3: Training 77 0.88 1.14 80.95*** 0.193
(outlier-adjusted) 73 0.74 1.05 73.07*** 0.075
Q4: Integrity 77 0.89 1.14 80.97*** 0.196
(outlier-adjusted) 73 0.76 1.05 73.14*** 0.078
Q5: ITT 77 1.10 1.08 81.54*** 0.904
(outlier-adjusted) 73 0.98 1.00 74.27*** 0.857
Q6: N ⩾ 50 77 1.21 0.94 80.99*** 0.095
(outlier-adjusted) 73 1.05 0.94 74.07*** 0.419
Q7: Randomization 77 1.20 1.02 81.13*** 0.285
(outlier-adjusted) 73 1.07 0.95 73.89*** 0.406
Q8: Blinding 77 1.14 1.08 81.47*** 0.791
(outlier-adjusted) 73 0.98 1.00 74.20** 0.915
Quality sum score (outlier-adjusted) k intercept b I2 p
77 1.15 −0.01 81.52*** 0.837
73 0.82 0.03 74.11*** 0.520

ITT, analyses conducted on an intent-to-treat basis (as opposed to completer basis); k,  number of trials included in the analysis for the given comparison; p values refer to the comparison of trials meeting v. not meeting the quality criterion or the continuous moderator analyzed.

*p < 0.05, **p < 0.01, ***p < 0.001.